JP2014518240A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518240A5 JP2014518240A5 JP2014517749A JP2014517749A JP2014518240A5 JP 2014518240 A5 JP2014518240 A5 JP 2014518240A5 JP 2014517749 A JP2014517749 A JP 2014517749A JP 2014517749 A JP2014517749 A JP 2014517749A JP 2014518240 A5 JP2014518240 A5 JP 2014518240A5
- Authority
- JP
- Japan
- Prior art keywords
- structural formula
- compound
- thiadiazole
- piperazine
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11172324.3 | 2011-07-01 | ||
| EP11172324 | 2011-07-01 | ||
| PCT/EP2012/062778 WO2013004642A1 (en) | 2011-07-01 | 2012-06-29 | 1, 2, 4 -thiadiazol- 5 -ylpiperazine derivatives useful in the treatment neurodegenerative diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014518240A JP2014518240A (ja) | 2014-07-28 |
| JP2014518240A5 true JP2014518240A5 (enExample) | 2015-05-28 |
| JP5972367B2 JP5972367B2 (ja) | 2016-08-17 |
Family
ID=46545347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517749A Expired - Fee Related JP5972367B2 (ja) | 2011-07-01 | 2012-06-29 | 神経変性疾患の治療に有用な１，２，４−チアジアゾール−５−イルピペラジン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9023852B2 (enExample) |
| EP (1) | EP2726470B1 (enExample) |
| JP (1) | JP5972367B2 (enExample) |
| CN (1) | CN103619825B (enExample) |
| AU (1) | AU2012280420B2 (enExample) |
| CA (1) | CA2837247C (enExample) |
| ES (1) | ES2540956T3 (enExample) |
| PL (1) | PL2726470T3 (enExample) |
| WO (1) | WO2013004642A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6051218B2 (ja) * | 2011-08-17 | 2016-12-27 | リマインド・ナムローゼ・フエンノートシャップＲｅｍｙｎｄ Ｎｖ | アルツハイマー病等のタウオパチーの治療に有用なピペラジンチアジアゾール誘導体 |
| US10562869B2 (en) | 2014-03-17 | 2020-02-18 | Remynd Nv | Oxadiazole compounds |
| MX383697B (es) * | 2016-06-23 | 2025-03-14 | St Jude Childrens Res Hospital Inc | Moduladores de moleculas peque?as de pantotenato cinasas |
| EP3529245A4 (en) * | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
| MA47212A (fr) | 2017-01-06 | 2019-11-13 | Yumanity Therapeutics Inc | Méthodes de traitement de troubles neurologiques |
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES THEREOF |
| MX2020006754A (es) | 2017-12-27 | 2021-01-29 | St Jude Childrens Res Hospital Inc | Moduladores de molécula pequeña de pantotenato-cinasas. |
| WO2019133632A1 (en) | 2017-12-27 | 2019-07-04 | St. Jude Children's Research Hospital | Methods of treating disorders associated with castor |
| ES3043183T3 (en) | 2018-03-23 | 2025-11-25 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| MA54829A (fr) | 2019-01-24 | 2021-12-01 | Yumanity Therapeutics Inc | Composés et leurs utilisations |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| CN122206438A (zh) | 2023-11-13 | 2026-06-12 | 瑞敏德股份有限公司 | 用于在预防和/或治疗神经退行性障碍中使用的隔膜蛋白6的调节剂 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000051999A1 (en) * | 1999-03-03 | 2000-09-08 | American Home Products Corporation | New diazole derivatives as serotonergic agents |
| EP1175416B1 (en) * | 1999-04-26 | 2003-07-16 | Neurosearch A/S | Heteroaryl diazacycloalkanes, their preparation and use |
| DE102004032567A1 (de) * | 2004-07-05 | 2006-03-02 | Grünenthal GmbH | Substituierte 1-Propiolyl-piperazine |
| US7541359B2 (en) * | 2005-06-30 | 2009-06-02 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| GB0602335D0 (en) * | 2006-02-07 | 2006-03-15 | Remynd Nv | Thiadiazole Derivatives For The Treatment Of Neurodegenerative Diseases |
| AR059355A1 (es) * | 2006-02-07 | 2008-03-26 | Wyeth Corp | Inhibidores de 11-beta hsd1 |
-
2012
- 2012-06-29 WO PCT/EP2012/062778 patent/WO2013004642A1/en not_active Ceased
- 2012-06-29 PL PL12737238T patent/PL2726470T3/pl unknown
- 2012-06-29 EP EP20120737238 patent/EP2726470B1/en active Active
- 2012-06-29 AU AU2012280420A patent/AU2012280420B2/en not_active Ceased
- 2012-06-29 CN CN201280030881.0A patent/CN103619825B/zh not_active Expired - Fee Related
- 2012-06-29 US US14/127,779 patent/US9023852B2/en active Active
- 2012-06-29 CA CA2837247A patent/CA2837247C/en active Active
- 2012-06-29 ES ES12737238.1T patent/ES2540956T3/es active Active
- 2012-06-29 JP JP2014517749A patent/JP5972367B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Havrylyuk et al. | Synthesis of pyrazoline–thiazolidinone hybrids with trypanocidal activity | |
| JP2010516681A5 (enExample) | ||
| RU2015143643A (ru) | Соль омекамтива мекарбила и способ ее получения | |
| JP2009533369A5 (enExample) | ||
| AU2014225675B2 (en) | Benzoimidazol-2-yl pyrimidine modulators of the histamine H4 receptor | |
| JP2016512822A5 (enExample) | ||
| JP2018528182A5 (enExample) | ||
| EP3484895A1 (en) | Solid state forms of crisaborole | |
| EP2906554A1 (en) | Solid forms of nilotinib hydrochloride | |
| JP2015522037A (ja) | ベムラフェニブコリン塩の固体形態 | |
| JP2020512400A5 (enExample) | ||
| CN102046610A (zh) | 苯基哌嗪化合物和包含所述化合物的药物组合物及其用途 | |
| JP2011105685A (ja) | フェネチルアミン化合物の結晶 | |
| CN102295655A (zh) | 一种氧头孢烯类抗菌素中间体溶剂化物及其制备方法 | |
| JP4613501B2 (ja) | ５−保護アミノピリミジン化合物の製造方法 | |
| EP2941420B1 (en) | (4e)-4-(4-substituted benzylideneamino)-2,3-dihydro-3- substituted-2-thioxothiazole-5-carbonitriles as a2ar antagonist and process for preparation thereof | |
| CN102229578B (zh) | 一种2-芳胺基-1，3，4-噁二唑化合物的制备方法 | |
| JP5004643B2 (ja) | Ｎ−（２−アミノ−１，２−ジシアノビニル）ホルムアミジンの製造方法 | |
| IL291569B1 (en) | Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine | |
| US20190284161A1 (en) | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
| JP2017514845A5 (enExample) | ||
| CN103880750A (zh) | 一种替格列汀关键中间体的制备方法 | |
| CN105037331B (zh) | 瑞舒伐他汀中间体的制备方法 | |
| JP5064872B2 (ja) | Ｎ−（２−アミノ−１，２−ジシアノビニル）イミデート類の製造方法 | |
| WO2009116085A3 (en) | An improved process for the preparation of ziprasidone |